Contact
Biocat echoed the final meeting of the Consolider Epigenetics project, held on 12 and 13 May in Barcelona. Over the past 5 years that it has been running, this project has brought together the top European research groups in the field, including the IRB Barcelona Chromatin Structure and Function lab, led by Ferran Azorín. The project has come to an impressive end, with important findings in multiple sclerosis and cancer epigenetics and more than 150 scientific papers published in leading journals, like Cell Stem Cell, Nature Structural and Cancer Research.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
